|

Heplisav-B Injectable Product, 2-dose regimen Clinical Trials

1 actively recruiting trial across 1 location

Also known as: 2-dose regimen

Pipeline

Phase 4: 1

Top Sponsors

  • Mercy Medical Center1

Indications

  • Liver Disease1
  • Chronic Liver Disease1
  • Hepatitis B1
  • Cirrhosis, Liver1

Baltimore, Maryland1 trial

Comparison Between 2-dose Versus 3-dose Regimens of Heplisav B in Cirrhosis

Mercy Medical Center

Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.